ArticleJournal of thoracic disease2023

Neoadjuvant sintilimab plus chemotherapy for locally advanced resectable esophageal squamous cell carcinoma: a prospective, single-arm, phase II clinical trial (CY-NICE).

Yuzhen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.